Braeburn Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 295

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

  • Investments
  • 2

Braeburn General Information

Description

Manufacturer of pharmaceutical products intended to manage opioid use disorder. The company utilizes liquid-crystalline gel technology, subcutaneous injection delivery, and extended-release formulations, providing healthcare providers and patients with weekly buprenorphine injections, monthly buprenorphine injections, and long-acting therapeutic implants.

Contact Information

Website
www.braeburnrx.com
Formerly Known As
AT Pharmaceuticals, Braeburn Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 450 Plymouth Road
  • Suite 400
  • Plymouth Meeting, PA 19462
  • United States
+1 (610)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 450 Plymouth Road
  • Suite 400
  • Plymouth Meeting, PA 19462
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Braeburn Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Braeburn‘s full profile, request access.

Request a free trial

Braeburn Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended to manage opioid use disorder. The company utilizes liquid-crystalline
Drug Discovery
Plymouth Meeting, PA
295 As of 2026

North Chesterfield, VA
 

Lund, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Braeburn Competitors (7)

One of Braeburn’s 7 competitors is Indivior, a Corporate Backed or Acquired company based in North Chesterfield, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Indivior Corporate Backed or Acquired North Chesterfield, VA
Camurus Corporation Lund, Sweden
Ensysce Biosciences Formerly VC-backed La Jolla, CA
Novaremed Venture Capital-Backed Basel, Switzerland
BioXcel Therapeutics Formerly VC-backed New Haven, CT
You’re viewing 5 of 7 competitors. Get the full list »

Braeburn Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Braeburn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170028811-A1 Vehicle extreme temperature safety systems Active 27-Feb-2015
WO-2016138518-A1 Vehicle extreme temperature safety systems Inactive 27-Feb-2015
US-10457113-B2 Vehicle extreme temperature safety systems and methods Inactive 27-Feb-2015 B60H1/00742

Braeburn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Braeburn Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Braeburn‘s full profile, request access.

Request a free trial

Braeburn Investments (2)

Braeburn’s most recent deal was a Corporate Asset Purchase with Endo Pharmaceuticals (Schizophernia Treatment). The deal was made on 01-May-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Endo Pharmaceuticals (Schizophernia Treatment) 01-May-2015 Corporate Asset Purchase Buildings and Property
Titan Pharmaceuticals 13-Nov-2013 PIPE Pharmaceuticals
To view Braeburn’s complete investments history, request access »

Braeburn Exits (1)

Braeburn’s most recent exit was on 13-Nov-2013 from Titan Pharmaceuticals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Titan Pharmaceuticals 13-Nov-2013 Completed
To view Braeburn’s complete exits history, request access »

Braeburn FAQs

  • When was Braeburn founded?

    Braeburn was founded in 2012.

  • Where is Braeburn headquartered?

    Braeburn is headquartered in Plymouth Meeting, PA.

  • What is the size of Braeburn?

    Braeburn has 295 total employees.

  • What industry is Braeburn in?

    Braeburn’s primary industry is Drug Discovery.

  • Is Braeburn a private or public company?

    Braeburn is a Private company.

  • What is Braeburn’s current revenue?

    The current revenue for Braeburn is .

  • How much funding has Braeburn raised over time?

    Braeburn has raised $133M.

  • Who are Braeburn’s investors?

    Apple Tree Partners (ATP), Avista Healthcare Partners, New Leaf Venture, and Wellington Management have invested in Braeburn.

  • Who are Braeburn’s competitors?

    Indivior, Camurus, Ensysce Biosciences, Novaremed, and BioXcel Therapeutics are some of the 7 competitors of Braeburn.

  • When was Braeburn acquired?

    Braeburn was acquired on 01-Apr-2026.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process